Description du projet
Navigation dans les tissus mous: des ingénieurs biomédicaux et des médecins en début de carrière développent de nouvelles solutions
La navigation dans les tissus mous au cours d’une intervention chirurgicale, en particulier la résection chirurgicale de tumeurs, se heurte à la difficulté d’atteindre la précision souhaitée dans des organes déformables qui bougent en réponse à la respiration, aux battements de cœur et à l’intervention elle-même. De nombreux patients souffrant d’un carcinome hépatocellulaire, le principal type de cancer primitif du foie, ne sont pas éligibles pour une résection, et le pronostic d’autres patients est affecté par les difficultés inhérentes à la navigation dans les tissus mous. Avec le soutien du programme Actions Marie Skłodowska-Curie, le projet HiPerNav formera des chercheurs en début de carrière aux traitements peu invasifs, à l’ingénierie biomédicale, aux méthodologies de recherche et à l’esprit d’entreprise. La recherche fera le lien entre les idées théoriques et la pratique clinique en testant des prototypes et en développant des solutions et des outils concrets.
Objectif
Primary liver cancer, which consists predominantly of hepatocellular carcinoma (HCC), is the fifth most common cancer worldwide and the third most common cause of cancer mortality. A successful surgical resection of HCC requires complete removal of the tumour while sparing as much healthy tissue as possible. Due to technical and clinical difficulties relatively low percentage of patients are eligible for resection. There is an urgent need to increase the patient eligibility and improve the survival prognosis after liver interventions. HiPerNav will train early stage researchers (biomedical engineers and medical doctors) to become international leading in key areas of expertise through a novel coordinated plan of individual research projects addressing specific bottlenecks in soft tissue navigation for improved treatment of liver cancer. The multi-disciplinary dialogue and work between clinicians and biomedical engineers is crucial to address these bottlenecks. By providing researchers with knowledge and training within specific topics from minimally invasive treatment, biomedical engineering, research methodologies, innovation and entrepreneurship, the link between academic research and industry will be strengthened. This allows for easy transfer of promising results from the research projects to commercially exploitable solutions. The global image guided surgery devices market is promising; it was valued at USD 2.76 billion in 2013 and is projected to expand 6.4% from 2014 to 2022 to reach USD 4.80 billion in 2022. The market for soft-tissue navigation is still in its infancy, mainly due to challenges in achieved accuracy for targeting deformable and moving organs. By providing multi-disciplinary training, the researchers in this consortium of international leading research institutions, universities and industry will initiate true translational research from academic theoretical ideas to the clinical testing of prototype, developed solutions and tools.
Champ scientifique
- medical and health sciencesmedical biotechnology
- medical and health sciencesclinical medicineoncologyliver cancer
- medical and health sciencesbasic medicineanatomy and morphology
- medical and health sciencesclinical medicinesurgerysurgical specialties
- medical and health sciencesclinical medicineoncologypancreatic cancer
Programme(s)
Régime de financement
MSCA-ITN-ETN - European Training NetworksCoordinateur
0450 Oslo
Norvège